Editor’s Note: The following guest post is published with the permission of its author, Edward J. Schloss, MD, (Twitter ID @EJSMD) the medical director of cardiac electrophysiology at Christ Hospital ...

ROCHESTER, NY — Event-detection algorithms used by the wearable cardioverter-defibrillator (LifeVest WCD, Zoll Medical) may be fooled into delivering an inappropriate shock in patients with implanted ...

Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the ...

Data Published in JACC: Clinical Electrophysiology and to be Presented at American Heart Association Scientific Sessions Demonstrates the Potential of Investigational Algorithms in Medtronic Micra ...

Am J Geriatr Cardiol. 2005;14(1):35-38. A second large (N=2010) trial, Mode Selection Trial (MOST), [15] was published in 2002. This study was restricted to patients with SSS. No difference was seen ...

In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

(HealthDay)—A leadless anti-tachycardia pacemaker (LP) and subcutaneous implantable cardioverter defibrillator (S-ICD) are feasible in animal models, according to a study published online May 12 in ...